Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis

NCT03919500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1285

Enrollment

OTHER

Sponsor class

Conditions

Premature Infant

Interventions

DRUG: EPO
DRUG: Normal saline

Sponsor

Zhengzhou University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]